+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Male Infertility Market by Test (Computer-Assisted Semen Analysis, DNA Fragmentation Technique, Microscopic Examination), Treatment (Assisted Reproductive Technology, Medication) - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904835
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Male Infertility Market size was estimated at USD 1.22 billion in 2023, USD 1.50 billion in 2024, and is expected to grow at a CAGR of 22.34% to reach USD 5.04 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Male Infertility Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Male Infertility Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Male Infertility Market, highlighting leading vendors and their innovative profiles. These include Andrology Solutions, Bayer AG, Cadila Pharmaceuticals by Zydus Lifesciences Limited, CinnaGen Co., EMD Sereno, Inc. by Merck KGaA, Endo International PLC, Halotech DNA S.L., Intas Pharmaceuticals Ltd., Sanofi SA, SCSA Diagnostics, Inc., Theramex, and Vitrolife Sweden AB.

Market Segmentation & Coverage

This research report categorizes the Male Infertility Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Test
    • Computer-Assisted Semen Analysis
    • DNA Fragmentation Technique
    • Microscopic Examination
    • Oxidative Stress Analysis
    • Sperm Agglutination
    • Sperm Penetration Assay
  • Treatment
    • Assisted Reproductive Technology
    • Medication
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Male Infertility Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Male Infertility Market?
  3. What are the technology trends and regulatory frameworks in the Male Infertility Market?
  4. What is the market share of the leading vendors in the Male Infertility Market?
  5. Which modes and strategic moves are suitable for entering the Male Infertility Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Male Infertility Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of infertility in male due to lifestyle and environmental issues
5.1.1.2. Rising adoption of assisted reproductive technologies
5.1.1.3. Introduction of technology-driven male infertility treatments options
5.1.2. Restraints
5.1.2.1. High cost of treatment
5.1.3. Opportunities
5.1.3.1. Rising medical tourism
5.1.3.2. Growing awareness and changing lifestyle with rising R&D expenditure
5.1.4. Challenges
5.1.4.1. Social stigma
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Male Infertility Market, by Test
6.1. Introduction
6.2. Computer-Assisted Semen Analysis
6.3. DNA Fragmentation Technique
6.4. Microscopic Examination
6.5. Oxidative Stress Analysis
6.6. Sperm Agglutination
6.7. Sperm Penetration Assay
7. Male Infertility Market, by Treatment
7.1. Introduction
7.2. Assisted Reproductive Technology
7.3. Medication
8. Americas Male Infertility Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Male Infertility Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Male Infertility Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Andrology Solutions
12.1.2. Bayer AG
12.1.3. Cadila Pharmaceuticals by Zydus Lifesciences Limited
12.1.4. CinnaGen Co.
12.1.5. EMD Sereno, Inc. by Merck KGaA
12.1.6. Endo International PLC
12.1.7. Halotech DNA S.L.
12.1.8. Intas Pharmaceuticals Ltd.
12.1.9. Sanofi SA
12.1.10. SCSA Diagnostics, Inc.
12.1.11. Theramex
12.1.12. Vitrolife Sweden AB
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. MALE INFERTILITY MARKET RESEARCH PROCESS
FIGURE 2. MALE INFERTILITY MARKET SIZE, 2022 VS 2030
FIGURE 3. MALE INFERTILITY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MALE INFERTILITY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. MALE INFERTILITY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. MALE INFERTILITY MARKET DYNAMICS
FIGURE 7. MALE INFERTILITY MARKET SIZE, BY TEST, 2022 VS 2030 (%)
FIGURE 8. MALE INFERTILITY MARKET SIZE, BY TEST, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
FIGURE 10. MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES MALE INFERTILITY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES MALE INFERTILITY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. MALE INFERTILITY MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. MALE INFERTILITY MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. MALE INFERTILITY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. MALE INFERTILITY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MALE INFERTILITY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 6. MALE INFERTILITY MARKET SIZE, BY COMPUTER-ASSISTED SEMEN ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MALE INFERTILITY MARKET SIZE, BY DNA FRAGMENTATION TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MALE INFERTILITY MARKET SIZE, BY MICROSCOPIC EXAMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. MALE INFERTILITY MARKET SIZE, BY OXIDATIVE STRESS ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MALE INFERTILITY MARKET SIZE, BY SPERM AGGLUTINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. MALE INFERTILITY MARKET SIZE, BY SPERM PENETRATION ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 13. MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. MALE INFERTILITY MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 22. CANADA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 23. CANADA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 24. MEXICO MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 25. MEXICO MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES MALE INFERTILITY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 34. CHINA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 35. CHINA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 36. INDIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 37. INDIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 40. JAPAN MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 41. JAPAN MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. THAILAND MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 53. THAILAND MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. DENMARK MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 60. DENMARK MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. EGYPT MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 62. EGYPT MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 63. FINLAND MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 64. FINLAND MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. FRANCE MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 66. FRANCE MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. GERMANY MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 68. GERMANY MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 71. ITALY MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 72. ITALY MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. NORWAY MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 78. NORWAY MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. POLAND MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 80. POLAND MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. QATAR MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 82. QATAR MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. SPAIN MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 90. SPAIN MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. TURKEY MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 96. TURKEY MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. MALE INFERTILITY MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 102. MALE INFERTILITY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 103. MALE INFERTILITY MARKET LICENSE & PRICING

Companies Mentioned

  • Andrology Solutions
  • Bayer AG
  • Cadila Pharmaceuticals by Zydus Lifesciences Limited
  • CinnaGen Co.
  • EMD Sereno, Inc. by Merck KGaA
  • Endo International PLC
  • Halotech DNA S.L.
  • Intas Pharmaceuticals Ltd.
  • Sanofi SA
  • SCSA Diagnostics, Inc.
  • Theramex
  • Vitrolife Sweden AB

Methodology

Loading
LOADING...

Table Information